Everyone would love to find the perfect stock. But will you ever really find a stock that gives you everything you could possibly want?
One thing's for sure: If you don't look, you'll never find truly great investments. So let's first take a look at what you'd want to see from a perfect stock, and then decide if Altria
The quest for perfection
When you're looking for great stocks, you have to do your due diligence. It's not enough to rely on a single measure, because a stock that looks great based on one factor may turn out to be horrible in other ways. The best stocks, however, excel in many different areas, which all come together to make up a very attractive picture.
Some of the most basic yet important things to look for in a stock are:
- Growth. Expanding businesses show healthy revenue growth. While past growth is no guarantee that revenue will keep rising, it's certainly a better sign than a stagnant top line.
- Margins. Higher sales don't mean anything if a company can't turn them into profits. Strong margins ensure a company is able to turn revenue into profit.
- Balance sheet. Debt-laden companies have banks and bondholders competing with shareholders for management's attention. Companies with strong balance sheets don't have to worry about the distraction of debt.
- Money-making opportunities. Companies need to be able to turn their resources into profitable business opportunities. Return on equity helps measure how well a company is finding those opportunities.
- Valuation. You can't afford to pay too much for even the best companies. Earnings multiples are simple, but using normalized figures gives you a sense of how valuation fits into a longer-term context.
- Dividends. Investors are demanding tangible proof of profits, and there's nothing more tangible than getting a check every three months. Companies with solid dividends and strong commitments to increasing payouts treat shareholders well.
With those factors in mind, let's take a closer look at Altria.
What We Want to See
Pass or Fail?
|Growth||5-Year Annual Revenue Growth > 15%||6.4%*||fail|
|1-Year Revenue Growth > 12%||0.8%||fail|
|Margins||Gross Margin > 35%||53.6%||pass|
|Net Margin > 15%||20.7%||pass|
|Balance Sheet||Debt to Equity < 50%||269.5%||fail|
|Current Ratio > 1.3||1.68||pass|
|Opportunities||Return on Equity > 15%||88.0%||pass|
|Valuation||Normalized P/E < 20||14.82||pass|
|Dividends||Current Yield > 2%||6.2%||pass|
|5-Year Dividend Growth > 10%||12.8%**||pass|
|Total Score||7 out of 10|
Source: Capital IQ, a division of Standard and Poor's. *Reflects adjusted figures accounting for spinoffs of Kraft and Philip Morris International. **Annualized dividend growth since June 2008, which was first dividend after Philip Morris International spinoff. Total score = number of passes.
Altria scores an impressive 7. Moreover, even though the company loses points for its lack of strong revenue growth, it's hard to fault Altria for it. With such a large, mature business, it's no surprise that the company falls short on growth numbers.
Altria has gone from a diversified giant to a pure play on the U.S. tobacco market. Having divested itself of Philip Morris International
The tobacco business is quite lucrative, with competitors Reynolds American
No stock is a sure thing, but some stocks are a lot closer to perfect than others. By looking for the perfect stock, you'll go a long way toward improving your investing prowess and learning how to separate out the best investments from the rest.
True to its name, The Motley Fool is made up of a motley assortment of writers and analysts, each with a unique perspective; sometimes we agree, sometimes we disagree, but we all believe in the power of learning from each other through our Foolish community.
Fool contributor Dan Caplinger doesn't own shares of the companies mentioned in this article. Philip Morris International is a Motley Fool Global Gains selection. The Fool owns shares of Altria and Philip Morris International. Try any of our Foolish newsletters today, free for 30 days. The Fool has a disclosure policy.